Crossmark

Circ_0051079 functions as an oncogenic regulator in osteosarcoma by leading to MAFB expression upregulation by competitively interacting with miR-1286

Crossref DOI link: https://doi.org/10.1186/s13018-022-03297-w

Published Online: 2022-09-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Zhong

Chen, Pengcheng

Jia, Ruipeng

Liu, Yiheng
Funding

Funding for this research was provided by:

the key research and development projects of Hainan Province (social development direction, ZDYF2022SHF2081)
License Information

Text and Data Mining valid from 2022-09-24

Version of Record valid from 2022-09-24
More Information

Article History

Received: 30 December 2021

Accepted: 24 August 2022

First Online: 24 September 2022

Declarations

:

: Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of Haikou Affiliated Hospital of Central South University Xiangya School of Medicine.

: Not applicable.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below